Expression of Tau protein in rats with cognitive dysfunction induced by cerebral hypoperfusion
- PMID: 26770632
- PMCID: PMC4694532
Expression of Tau protein in rats with cognitive dysfunction induced by cerebral hypoperfusion
Abstract
The aim of this study was to investigate the relationship between chronic cerebral hypoperfusion and the occurrence and development of Alzheimer's disease (AD). A cerebral hypoperfusion rat model was established by two vessels occlusion (2VO). The cognitive function of the rats with chronic cerebral hypoperfusion and the expression of p-Tau protein in the hippocampus were observed dynamically. Before the operation, no differences were observed in the cognitive functions of the control and 2VO group (P > 0.05). However, a significant difference was found at 2, 4, 8, and 12 weeks after the operation. The shock number required to reach the "learned" standard in the 2VO group increased remarkably compared with that of the control group (P < 0.01). With the passage of time, the shock number in the model group increased gradually. The p-Tau-positive cells in the CA1 region of the hippocampus also increased markedly in the model group in a time-dependent manner as compared with that in the control group (P < 0.01). Cerebral hypoperfusion can cause and aggravate the phosphorylation of Tau protein in the brain, leading to cognitive dysfunction. Therefore, this protein is an important initiating and promoting factor involved in the development of AD.
Keywords: Alzheimer’s disease; Cerebral hypoperfusion; cognitive dysfunction; phosphorylated Tau protein.
Figures



Similar articles
-
Limb Ischemic Conditioning Improved Cognitive Deficits via eNOS-Dependent Augmentation of Angiogenesis after Chronic Cerebral Hypoperfusion in Rats.Aging Dis. 2018 Oct 1;9(5):869-879. doi: 10.14336/AD.2017.1106. eCollection 2018 Oct. Aging Dis. 2018. PMID: 30271664 Free PMC article.
-
Neuronal damage, central cholinergic dysfunction and oxidative damage correlate with cognitive deficits in rats with chronic cerebral hypoperfusion.Neurobiol Learn Mem. 2014 Mar;109:7-19. doi: 10.1016/j.nlm.2013.11.016. Epub 2013 Dec 6. Neurobiol Learn Mem. 2014. Retraction in: Neurobiol Learn Mem. 2015 Dec;126:87. doi: 10.1016/j.nlm.2015.11.001. PMID: 24315928 Retracted.
-
Permanent, bilateral common carotid artery occlusion in the rat: a model for chronic cerebral hypoperfusion-related neurodegenerative diseases.Brain Res Rev. 2007 Apr;54(1):162-80. doi: 10.1016/j.brainresrev.2007.01.003. Epub 2007 Jan 18. Brain Res Rev. 2007. PMID: 17296232 Review.
-
BMSCs transplantation improves cognitive impairment via up-regulation of hippocampal GABAergic system in a rat model of chronic cerebral hypoperfusion.Neuroscience. 2015 Dec 17;311:464-73. doi: 10.1016/j.neuroscience.2015.10.055. Epub 2015 Nov 3. Neuroscience. 2015. PMID: 26545982
-
Cerebral hypoperfusion and glucose hypometabolism: Key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer's disease.J Neurosci Res. 2017 Apr;95(4):943-972. doi: 10.1002/jnr.23777. Epub 2016 Jun 27. J Neurosci Res. 2017. PMID: 27350397 Review.
Cited by
-
Embelin Improves the Spatial Memory and Hippocampal Long-Term Potentiation in a Rat Model of Chronic Cerebral Hypoperfusion.Sci Rep. 2019 Oct 10;9(1):14507. doi: 10.1038/s41598-019-50954-y. Sci Rep. 2019. PMID: 31601902 Free PMC article.
-
Inhibition of MiR-122 Decreases Cerebral Ischemia-reperfusion Injury by Upregulating DJ-1-Phosphatase and Tensin Homologue Deleted on Chromosome 10 (PTEN)/Phosphonosinol-3 Kinase (PI3K)/AKT.Med Sci Monit. 2020 Feb 15;26:e915825. doi: 10.12659/MSM.915825. Med Sci Monit. 2020. PMID: 32061171 Free PMC article.
-
Hexahydrocurcumin Attenuates Neuronal Injury and Modulates Synaptic Plasticity in Chronic Cerebral Hypoperfusion in Rats.Mol Neurobiol. 2024 Jul;61(7):4304-4317. doi: 10.1007/s12035-023-03821-x. Epub 2023 Dec 12. Mol Neurobiol. 2024. PMID: 38087168
-
Neuroprotection Targeting Protein Misfolding on Chronic Cerebral Hypoperfusion in the Context of Metabolic Syndrome.Front Neurosci. 2018 May 31;12:339. doi: 10.3389/fnins.2018.00339. eCollection 2018. Front Neurosci. 2018. PMID: 29904335 Free PMC article. Review.
-
Cerebral Hypoperfusion and Other Shared Brain Pathologies in Ischemic Stroke and Alzheimer's Disease.Transl Stroke Res. 2018 Jun;9(3):238-250. doi: 10.1007/s12975-017-0570-2. Epub 2017 Oct 2. Transl Stroke Res. 2018. PMID: 28971348 Free PMC article. Review.
References
-
- Zhang R, Liu J, Khan A, Tseng B, Tarumi T, Armstrong K, Hill C, Martin-Cook K, Weiner M, Cullum M. Brain hypoperfusion and neurovascular decoupling in amnestic mild cognitive impairment. Alzheimers Dement. 2013;9:775.
-
- Ferreira ED, Romanini CV, Mori MA, de Oliveira RM, Milani H. Middle-aged, but not young, rats develop cognitive impairment and cortical neurodegeneration following the four-vessel occlusion/internal carotid artery model of chronic cerebral hypoperfusion. Eur J Neurosci. 2011;34:1131–1140. - PubMed
-
- De la Torre JC. Is Alzheimer’s disease preceded by neurodegeneration or cerebral hypoperfusion? Ann Neurol. 2005;57:783–784. - PubMed
-
- Vemuri P, Przybelski SA, Gunter JL, Senjem ML, Boeve BF, Knopman DS, Petersen RC, Jack CR. Quantitative measurement of cerebral hypoperfusion and atrophy in Alzheimer’s disease using MRI. Alzheimers Dement. 2009;5:78.
LinkOut - more resources
Full Text Sources
Miscellaneous